Charles River Laboratories International, Inc. (CRL) has a market capitalization of $8.83B and trades at $179.31. The 52-week range is 91.86-228.88.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -61.6, Earnings Per Share (EPS) of $-2.91, annual revenue of $4.02B.
The stock has a beta of 1.62, operates in the Healthcare sector.
